These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 29505111)

  • 41. Identification of tissue cyst wall components by transcriptome analysis of in vivo and in vitro Toxoplasma gondii bradyzoites.
    Buchholz KR; Fritz HM; Chen X; Durbin-Johnson B; Rocke DM; Ferguson DJ; Conrad PA; Boothroyd JC
    Eukaryot Cell; 2011 Dec; 10(12):1637-47. PubMed ID: 22021236
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Toxoplasma gondii GRA60 is an effector protein that modulates host cell autonomous immunity and contributes to virulence.
    Nyonda MA; Hammoudi PM; Ye S; Maire J; Marq JB; Yamamoto M; Soldati-Favre D
    Cell Microbiol; 2021 Feb; 23(2):e13278. PubMed ID: 33040458
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Induction of mitotic S-phase of host and neighboring cells by Toxoplasma gondii enhances parasite invasion.
    Lavine MD; Arrizabalaga G
    Mol Biochem Parasitol; 2009 Mar; 164(1):95-9. PubMed ID: 19111577
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phosphorylation of
    Young JC; Broncel M; Teague H; Russell MRG; McGovern OL; Renshaw M; Frith D; Snijders AP; Collinson L; Carruthers VB; Ewald SE; Treeck M
    mSphere; 2020 Sep; 5(5):. PubMed ID: 32907954
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of strain-specific phenotypes associated with knockout of dense granule protein 9 in Toxoplasma gondii.
    Guo H; Gao Y; Jia H; Moumouni PFA; Masatani T; Liu M; Lee SH; Galon EM; Li J; Li Y; Tumwebaze MA; Benedicto B; Xuan X
    Mol Biochem Parasitol; 2019 Apr; 229():53-61. PubMed ID: 30849416
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Two old drugs, NVP-AEW541 and GSK-J4, repurposed against the Toxoplasma gondii RH strain.
    Liu S; Wu M; Hua Q; Lu D; Tian Y; Yu H; Cheng L; Chen Y; Cao J; Hu X; Tan F
    Parasit Vectors; 2020 May; 13(1):242. PubMed ID: 32393321
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Toxoplasma gondii--intracellular parasite].
    Długońska H
    Wiad Parazytol; 2002; 48(1):23-8. PubMed ID: 16883700
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficient invasion by Toxoplasma depends on the subversion of host protein networks.
    Guérin A; Corrales RM; Parker ML; Lamarque MH; Jacot D; El Hajj H; Soldati-Favre D; Boulanger MJ; Lebrun M
    Nat Microbiol; 2017 Oct; 2(10):1358-1366. PubMed ID: 28848228
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assays for Monitoring Toxoplasma gondii Infectivity in the Laboratory Mouse.
    Wang Q; Sibley LD
    Methods Mol Biol; 2020; 2071():99-116. PubMed ID: 31758448
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rhoptries are major players in Toxoplasma gondii invasion and host cell interaction.
    Dubremetz JF
    Cell Microbiol; 2007 Apr; 9(4):841-8. PubMed ID: 17346309
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Toxoplasma gondii stabilises tetrameric complexes of tyrosine-phosphorylated signal transducer and activator of transcription-1 and leads to its sustained and promiscuous DNA binding.
    Nast R; Staab J; Meyer T; Lüder CGK
    Cell Microbiol; 2018 Nov; 20(11):e12887. PubMed ID: 29968354
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Toxoplasma gondii secretory proteins and their role in invasion and pathogenesis.
    Zhang Y; Lai BS; Juhas M; Zhang Y
    Microbiol Res; 2019 Oct; 227():126293. PubMed ID: 31421715
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Toxoplasmosis: a persisting challenge.
    Lüder CG; Bohne W; Soldati D
    Trends Parasitol; 2001 Oct; 17(10):460-3. PubMed ID: 11587941
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Toxoplasma MIC2 is a major determinant of invasion and virulence.
    Huynh MH; Carruthers VB
    PLoS Pathog; 2006 Aug; 2(8):e84. PubMed ID: 16933991
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of protective immune responses induced by DNA vaccines encoding Toxoplasma gondii surface antigen 1 (SAG1) and 14-3-3 protein in BALB/c mice.
    Meng M; He S; Zhao G; Bai Y; Zhou H; Cong H; Lu G; Zhao Q; Zhu XQ
    Parasit Vectors; 2012 Nov; 5():273. PubMed ID: 23181694
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Functional analysis of Toxoplasma gondii protease inhibitor 1.
    Morris MT; Coppin A; Tomavo S; Carruthers VB
    J Biol Chem; 2002 Nov; 277(47):45259-66. PubMed ID: 12228242
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oxidative stress generated during monensin treatment contributes to altered Toxoplasma gondii mitochondrial function.
    Charvat RA; Arrizabalaga G
    Sci Rep; 2016 Mar; 6():22997. PubMed ID: 26976749
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification and characterization of Letm1 gene in Toxoplasma gondii.
    Chang L; Zhang X; Gong P; Wang Y; Du B; Li J
    Acta Biochim Biophys Sin (Shanghai); 2019 Jan; 51(1):78-87. PubMed ID: 30423025
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Proximity-Labeling Reveals Novel Host and Parasite Proteins at the
    Cygan AM; Jean Beltran PM; Mendoza AG; Branon TC; Ting AY; Carr SA; Boothroyd JC
    mBio; 2021 Dec; 12(6):e0026021. PubMed ID: 34749525
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Functional Characterization of Dense Granule Proteins in
    Bai MJ; Wang JL; Elsheikha HM; Liang QL; Chen K; Nie LB; Zhu XQ
    Front Cell Infect Microbiol; 2018; 8():300. PubMed ID: 30211128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.